Pharmacology Examination MCQs | MCQ Quiz | OmpathStudy Kenya

Practice 42 MCQs on Pharmacology Examination MCQs with OmpathStudy. Built for Kenyan medical and health students to revise key concepts and prepare for exams.

Questions, Answers & Explanations

  1. Q1. A patient receives a drug dose of 500 mg daily. To express this dose normalized to body weight for a 70 kg patient, what unit would be most appropriate?

    Answer: mg/kg/day

    Explanation: The dosage unit mg/kg/day includes both the dose per unit body weight and exposure duration, making it the standard unit in toxicology and pharmacology for comparing doses across individuals of different weights. For this patient, it would be approximately 7.14 mg/kg/day.

  2. Q2. The LD50 of a new compound is determined to be 200 mg/kg, while its ED50 is 20 mg/kg. What is the Therapeutic Index (TI) of this drug?

    Answer: 180

    Explanation: The Therapeutic Index is calculated as LD50/ED50. In this case: 200/20 = 10. A TI of 10 indicates the drug has a reasonable margin of safety, as the lethal dose is 10 times higher than the effective dose. Drugs with higher TI values are generally considered safer.

  3. Q3. Which of the following best describes the "threshold dose" in a dose-response relationship?

    Answer: The dose below which no toxic response occurs or can be measured

    Explanation: The threshold dose represents the point where the body's ability to detoxify or repair effects is not yet exceeded. Below this dose, no observable adverse effects occur. This is a fundamental assumption in dose-response relationships for non-carcinogenic substances.

  4. Q4. A drug has an LD01 of 100 mg/kg and an ED99 of 80 mg/kg. What is the Margin of Safety (MOS)?

    Answer: 1.25

    Explanation: The Margin of Safety is calculated as LD01/ED99 = 100/80 = 1.25. A MOS less than 1 would indicate that the dose causing lethality in 1% of the population overlaps with the dose needed for 99% effectiveness, which is dangerous. This drug has a narrow margin of safety.

  5. Q5. According to toxicity scales, a substance with an LD50 of 400 mg/kg would be classified as

    Answer: Moderately toxic

    Explanation: The standard toxicity scale classifies substances with LD50 values between 50-500 mg/kg as moderately toxic. Extremely toxic substances have LD50 ≤ 50 mg/kg, slightly toxic 0.5-5 g/kg, and relatively harmless 5 g/kg.

  6. Q6. In dose-response curves, "potency" refers to

    Answer: The range of doses over which a drug produces increasing responses

    Explanation: Potency relates to the dose required to achieve a given response - more potent drugs require lower doses. It is reflected in the position of the dose-response curve along the dose axis. Efficacy (option C) refers to the maximum response, which is different from potency.

  7. Q7. NOAEL stands for

    Answer: No Observed Adverse Effect Level

    Explanation: NOAEL is the highest dose point at which no adverse or toxic effects are observed in experimental studies. It is used along with LOAEL (Lowest Observed Adverse Effect Level) to establish safe exposure limits for chemicals and drugs.

  8. Q8. A drug with TD50 of 150 mg and ED50 of 50 mg would have what relationship?

    Answer: TD50/ED50 = 3, indicating a relatively safe therapeutic window

    Explanation: The ratio of toxic dose to effective dose (150/50 = 3) represents the therapeutic index. A TI of 3 means the toxic dose is three times the effective dose. While not as safe as drugs with TI of 10 or higher, it still provides some margin for clinical use with careful monitoring.

  9. Q9. When comparing two drugs on a dose-response curve, if Drug A's curve is shifted to the left of Drug B's curve, this indicates

    Answer: Drug A is more potent than Drug B

    Explanation: A leftward shift means Drug A produces the same effect at a lower dose than Drug B, indicating greater potency. Efficacy is determined by the height (maximum) of the curve, not its position along the x-axis. ## SECTION B: INDIRECTLY ACTING SYMPATHOMIMETICS

  10. Q10. Tyramine produces its sympathomimetic effects primarily by which mechanism?

    Answer: Causing release of norepinephrine via NET reversal

    Explanation: Tyramine is taken up into nerve terminals by NET (norepinephrine transporter) and causes catecholamine release through reverse transport. This indirect mechanism distinguishes it from direct-acting sympathomimetics that bind directly to adrenergic receptors.

  11. Q11. Why is tyramine normally inactive when consumed orally in food?

    Answer: It undergoes extensive first-pass metabolism by MAO

    Explanation: Tyramine has very low bioavailability because it is readily metabolized by monoamine oxidase (MAO) present in the gastrointestinal endothelium and liver. This explains why it only produces significant effects when MAO is inhibited or when administered parenterally.

  12. Q12. A patient taking a nonselective MAO inhibitor consumes aged cheese containing high tyramine levels. What is the most likely consequence?

    Answer: Hypertensive crisis and tachycardia

    Explanation: When MAO is inhibited, dietary tyramine is not metabolized and reaches the systemic circulation. This leads to massive norepinephrine release from nerve terminals, causing dangerous elevations in blood pressure and heart rate, known as the "tyramine reaction" or "cheese effect."

  13. Q13. Amphetamine's mechanism of action differs from tyramine in that amphetamine

    Answer: Crosses the blood-brain barrier to produce CNS effects

    Explanation: Unlike tyramine, amphetamine can cross the blood-brain barrier and produce central nervous system stimulation. Both are indirectly acting sympathomimetics that cause catecholamine release, but amphetamine's CNS penetration is responsible for its stimulant and abuse potential.

  14. Q14. Cocaine blocks the reuptake of neurotransmitters by inhibiting which transporters?

    Answer: NET, DAT, and SERT (all three monoamine transporters)

    Explanation: Cocaine is a non-selective inhibitor that blocks all three monoamine reuptake transporters: NET (norepinephrine), DAT (dopamine), and SERT (serotonin). This results in increased synaptic concentrations of all three neurotransmitters, contributing to its stimulant and addictive properties.

  15. Q15. Tricyclic antidepressants like imipramine would be expected to

    Answer: Antagonize the effects of indirectly acting sympathomimetics

    Explanation: Imipramine blocks NET, preventing the uptake of indirectly acting sympathomimetics like tyramine into nerve terminals. Since these drugs must enter the nerve terminal to cause catecholamine release, blocking NET antagonizes their effects. This is an important drug interaction.

  16. Q16. Which statement about cocaine's cardiovascular toxicity is correct?

    Answer: It can cause both tachycardia and hypertension due to increased sympathetic outflow

    Explanation: Cocaine blocks monoamine reuptake, leading to increased norepinephrine at sympathetic nerve terminals. This causes simultaneous tachycardia and hypertension. Additionally, at higher doses, cocaine's sodium channel blocking effects can contribute to arrhythmias and cardiac toxicity.

  17. Q17. Repeated administration of tyramine leads to rapidly developing tolerance (tachyphylaxis) because

    Answer: The readily releasable pool of catecholamines becomes depleted

    Explanation: Tyramine releases catecholamines from a small cytoplasmic "readily releasable" pool. With repeated exposure, this pool becomes depleted faster than it can be replenished, resulting in tachyphylaxis. This is characteristic of indirectly acting sympathomimetics.

  18. Q18. Why does tyramine NOT produce psychoactive effects when administered systemically?

    Answer: It does not cross the blood-brain barrier

    Explanation: Tyramine and other monoamines cannot cross the blood-brain barrier due to tight junctions in cerebral capillaries and high concentrations of MAO and dopa decarboxylase in the capillary endothelium. This results in only peripheral sympathomimetic effects.

  19. Q19. Reserpine would antagonize the effects of indirectly acting sympathomimetics like tyramine if given

    Answer: Several hours to days before tyramine

    Explanation: Reserpine depletes catecholamines from nerve terminals by inhibiting VMAT (vesicular monoamine transporter). Since tyramine works by releasing stored catecholamines, it cannot work if the stores are depleted. However, depletion takes time to develop, so reserpine must be given well in advance.

  20. Q20. The combination of cocaine and ethanol in the body produces

    Answer: Cocaethylene, with longer half-life and similar toxicity

    Explanation: When cocaine and ethanol are consumed together, they undergo transesterification in the liver to form cocaethylene, which has a half-life of 3-4 hours (longer than cocaine's ~50 min) and shares similar pharmacology. This prolongs the "high" and may increase cardiotoxicity. ## SECTION C: HISTAMINE AND ANTIHISTAMINES

  21. Q21. Which enzyme catalyzes the conversion of L-histidine to histamine?

    Answer: Histidine decarboxylase

    Explanation: Histidine decarboxylase is the enzyme responsible for synthesizing histamine from the amino acid L-histidine. This occurs primarily in mast cells, basophils, and enterochromaffin cells in the stomach.

  22. Q22. The "triple response" following intradermal histamine injection consists of all of the following EXCEPT

    Answer: Vasoconstriction of surrounding vessels

    Explanation: The triple response includes: 1) flush (capillary/venule dilation), 2) flare (arteriolar dilation via axon reflex), and 3) wheal (increased capillary permeability causing edema). Vasoconstriction does not occur; all three components involve vasodilation and increased permeability.

  23. Q23. H2 receptor antagonists like ranitidine reduce gastric acid secretion by

    Answer: Blocking histamine stimulation of parietal cell H2 receptors

    Explanation: H2 blockers competitively antagonize histamine at H2 receptors on gastric parietal cells, preventing the histamine-mediated activation of adenylyl cyclase and subsequent stimulation of the proton pump. They do not directly block the pump itself (that's the mechanism of PPIs like omeprazole).

  24. Q24. First-generation H1 antihistamines like diphenhydramine cause sedation because they

    Answer: Cross the blood-brain barrier and block central H1 receptors

    Explanation: First-generation antihistamines are lipophilic and readily cross the blood-brain barrier, blocking H1 receptors in the CNS that mediate wakefulness and alertness. Second-generation antihistamines (like cetirizine, loratadine) are more polar and penetrate the brain poorly, causing minimal sedation.

  25. Q25. A unique side effect of cimetidine (but not other H2 blockers) in males is

    Answer: Gynecomastia and decreased libido

    Explanation: Cimetidine has anti-androgenic effects and increases prolactin secretion, which can lead to gynecomastia (breast enlargement), decreased libido, and impotence in males. This is specific to cimetidine and does not occur with other H2 blockers like ranitidine or famotidine.

  26. Q26. Which H1 antihistamine also has significant 5-HT (serotonin) antagonist properties?

    Answer: Cyproheptadine

    Explanation: Cyproheptadine is unique among H1 antihistamines in having potent 5-HT antagonist activity, particularly at 5-HT2 receptors. This dual action makes it useful for conditions beyond typical allergies, such as migraine prophylaxis and treatment of serotonin syndrome.

  27. Q27. Which G-protein type is coupled to H1 receptors?

    Answer: Gq (phospholipase C activation)

    Explanation: H1 receptors couple to Gq proteins, which activate phospholipase C (PLC). This produces IP3 and DAG as second messengers. IP3 increases intracellular Ca2+, leading to smooth muscle contraction, while DAG activates protein kinase C.

  28. Q28. The "flare" component of histamine's triple response is mediated by

    Answer: Axon reflex causing arteriolar dilation

    Explanation: The flare is a bright red area extending irregularly beyond the initial flush, caused by arteriolar dilation via axon reflex. This is a neurogenic response where sensory nerve stimulation causes reflex vasodilation in surrounding vessels.

  29. Q29. Betahistine, a histamine analog, is used clinically to treat

    Answer: Vertigo in Meniere's disease

    Explanation: Betahistine is a histamine H1 receptor agonist and H3 receptor antagonist used to reduce vertigo attacks in Meniere's disease. It is thought to work by improving microcirculation in the inner ear, though its exact mechanism remains unclear.

  30. Q30. Promethazine differs from other H1 antihistamines by also possessing

    Answer: Alpha-adrenergic blocking and local anesthetic properties

    Explanation: Promethazine is a phenothiazine derivative with multiple actions: H1 antagonism, alpha-adrenergic blockade, local anesthetic effects, and antimuscarinic activity. This explains its use in motion sickness, as an antiemetic, and its stronger sedative properties.

  31. Q31. What percentage of the body's serotonin is stored in enterochromaffin cells of the GI tract?

    Answer: 90%

    Explanation: Approximately 90% of the body's serotonin is synthesized and stored in enterochromaffin cells of the gastrointestinal tract. Only about 10% is found in platelets and the CNS. Despite this distribution, GI serotonin does not cross the blood-brain barrier.

  32. Q32. Which enzyme catalyzes the rate-limiting step in serotonin synthesis?

    Answer: Tryptophan hydroxylase

    Explanation: Tryptophan hydroxylase converts dietary tryptophan to 5-hydroxytryptophan in the rate-limiting step of serotonin synthesis. This is then converted to serotonin (5-HT) by amino acid decarboxylase.

  33. Q33. The 5-HT3 receptor differs from other serotonin receptors in that it is a

    Answer: Ligand-gated ion channel

    Explanation: 5-HT3 is the only serotonin receptor that is a ligand-gated ion channel (specifically for Na+ and K+). All other 5-HT receptors (5-HT1, 5-HT2, 5-HT4, 5-HT5, 5-HT6, 5-HT7) are G-protein coupled receptors.

  34. Q34. Ondansetron is used as an antiemetic primarily because it

    Answer: Blocks 5-HT3 receptors in the chemoreceptor trigger zone

    Explanation: Ondansetron is a selective 5-HT3 receptor antagonist. Blocking 5-HT3 receptors in the chemoreceptor trigger zone and vagal afferents effectively prevents nausea and vomiting, particularly from chemotherapy and post-operative settings.

  35. Q35. Sumatriptan is effective in treating acute migraine attacks because it

    Answer: Acts as a 5-HT1D agonist decreasing serotonin release

    Explanation: Sumatriptan is a selective 5-HT1D receptor agonist. Activation of presynaptic 5-HT1D receptors inhibits serotonin release and causes vasoconstriction of cranial vessels, both contributing to relief of acute migraine symptoms.

  36. Q36. Which 5-HT receptor subtype functions as an autoreceptor regulating serotonin release?

    Answer: 5-HT1D

    Explanation: 5-HT1B and 5-HT1D receptors function as presynaptic autoreceptors. When activated, they inhibit further serotonin release via negative feedback. This is the mechanism by which sumatriptan works in migraine - it activates 5-HT1D autoreceptors to reduce excessive serotonin release.

  37. Q37. Metoclopramide acts as a prokinetic agent primarily through

    Answer: 5-HT4 receptor agonism

    Explanation: Metoclopramide is a 5-HT4 receptor agonist that enhances GI motility by stimulating acetylcholine release in the enteric nervous system. It also has dopamine D2 antagonist and 5-HT3 antagonist properties, contributing to its antiemetic effects.

  38. Q38. Buspirone's anxiolytic effects are mediated through

    Answer: Partial agonism at 5-HT1A receptors

    Explanation: Buspirone is a partial agonist at 5-HT1A receptors, which mediates its anxiolytic effects. Unlike benzodiazepines, it doesn't enhance GABA activity, has no sedative or muscle relaxant properties, and takes several weeks to produce therapeutic effects.

  39. Q39. Which enzyme releases arachidonic acid from cell membrane phospholipids, initiating eicosanoid synthesis?

    Answer: Phospholipase A2

    Explanation: Phospholipase A2 is the enzyme that cleaves arachidonic acid from membrane phospholipids. This is the first and crucial step in eicosanoid biosynthesis, occurring during inflammation, allergy, and cell injury. The released arachidonic acid is then metabolized by COX or lipoxygenase pathways.

  40. Q40. Thromboxane A2 (TXA2) produced by platelets primarily causes

    Answer: Vasoconstriction and promotion of platelet aggregation

    Explanation: TXA2 is synthesized by platelets via the cyclooxygenase pathway and is a potent vasoconstrictor and platelet aggregator. This is crucial for hemostasis. Aspirin's antiplatelet effect comes from irreversibly inhibiting COX in platelets, thereby preventing TXA2 synthesis.

  41. Q41. 9 : Misoprostol (PGE2 analog) is used clinically to

    Answer: Both A and B

    Explanation: Misoprostol has multiple uses: it provides cytoprotection against NSAID-induced ulcers by reducing acid secretion and increasing mucus/bicarbonate production, and it's also used as an abortifacient due to its ability to cause uterine contractions. PGE2 and PGF2α preparations are used for labor induction.

  42. Q42. Prostacyclin (PGI2) synthesized by vascular endothelium has effects that are opposite to TXA2, specifically

    Answer: It causes vasodilation and inhibits platelet aggregation

    Explanation: PGI2 and TXA2 have opposing actions, creating a balance in hemostasis. While TXA2 (from platelets) promotes vasoconstriction and aggregation, PGI2 (from endothelium) causes vasodilation and inhibits aggregation. This balance is important in maintaining vascular homeostasis. ---

View on OmpathStudy